Founded in Winston-Salem, North Carolina, by corporate insurance professionals with deep roots in the healthcare sector. From our first day, we operated on a single principle: enterprise healthcare organizations deserve institutional-grade protection engineered specifically for their unique risk profiles.
Our founding team recognized a market gap that persisted for decades: general commercial insurers could not adequately underwrite the complex, intersecting risks of large-scale medical operations. Clinical liability, pharmaceutical supply chain exposure, regulatory risk, cyber threats to electronic health records, and catastrophic business interruption demands demanded a fundamentally different approach.
Early growth came through deep partnerships with regional health systems in the Carolinas and Virginia. National expansion followed through the 1990s as hospital consolidation created enterprise-scale clients that required matching enterprise-scale coverage. International licenses were obtained between 1998 and 2014, establishing our presence in the United Kingdom, Germany, France, the Netherlands, and beyond.
Today, the firm is licensed in 28 countries, maintains five international offices, and has never deviated from its founding mandate: bespoke corporate insurance for healthcare and pharmaceutical enterprises – and nothing else.
“Enterprise healthcare organizations deserve institutional-grade protection engineered specifically for their unique risk profiles.”
Founding Principle — 1984
First healthcare malpractice and professional liability policies written. The firm established with a mandate for B2B corporate healthcare insurance exclusively.
New York regional office established. First major hospital network accounts underwritten. Entry into multi-facility enterprise healthcare coverage.
First international policies written. Regulatory licensing secured in the United Kingdom, Germany, France, and the Netherlands. European operations launched from London.
Long-term reinsurance treaty established with Munich Re. Every policy written by the firm now carries Munich Re's global reinsurance backing, providing clients with institutional-level financial certainty.
Second major reinsurance arrangement established with Swiss Re. Dual reinsurance backing creates redundant capital depth that protects clients against even catastrophic institutional losses.
Middle East and Asia-Pacific expansion. Dubai office opens to serve GCC healthcare infrastructure growth. Singapore hub established for Southeast Asian pharmaceutical and medical logistics coverage.
Pharmaceutical certification support and business development consulting added as a dedicated practice. 150+ regulatory consultants onboarded across FDA, EMA, and WHO jurisdictions.
Regulatory licensing completed across all major global markets. The firm is now licensed and authorized to write corporate healthcare insurance in 28 countries across five continents.
Fortieth year of continuous operation. A+ Standard & Poor's rating reaffirmed. Maximum coverage capacity reaches $500M per policy. Hannover Re tri-reinsurer model formalized. 94% claims resolution rate maintained.
Our financial statements are audited annually by one of the Big Four accounting firms (Deloitte, KPMG, EY, or PwC). This ensures that our capital reserves, reinsurance arrangements, and claims liabilities are independently verified to institutional standards.
The A+ Standard & Poor's credit rating is not a legacy distinction – it is reaffirmed annually against the same rigorous criteria applied to major financial institutions. Our consistent rating over four decades reflects conservative underwriting, deep reserve maintenance, and the financial strength of our tri-reinsurer backing.
Regulatory compliance is managed across 28 jurisdictions by a dedicated compliance team and a network of 150+ local regulatory consultants. Licensing requirements vary significantly by country – maintaining active, compliant licenses in each jurisdiction requires continuous legal, actuarial, and operational investment that only a specialist firm can sustain.
“When a hospital network’s coverage fails, patients are at risk. When a pharmaceutical supply chain is uninsured, essential medicines may not reach their destination. We exist to ensure these failures never happen.”
We operate to the financial and ethical standards of an institution, not a broker. Our capital reserves, audit practices, and reinsurance arrangements reflect this commitment absolutely.
We do not adapt retail products to corporate needs. Every policy begins from first principles – exposure mapping, risk quantification, and bespoke terms designed for the specific enterprise.
Our average client relationship is 11 years. We design for permanence. As a client’s operations evolve, their coverage evolves with them through the same account management relationship.
B2B corporate inquiries only. Our specialists respond within 24 business hours.
Submit Corporate Inquiry